Reduced TβRII expression was observed in approximately 25% of hepatocellular carcinoma (HCC) patients; this event is associated with aggressive phenotype of HCC and intrahepatic metastasis. The gene discussed is TGFBR2; the disease is hepatocellular carcinoma.